Keyphrases
Inhibitory Effect
100%
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
100%
Vascular Smooth muscle Cells
100%
Adenosine Uptake
100%
Adenosine Transport
100%
Sulindac Sulfide
83%
Human Aortic Smooth muscle Cells (HASMCs)
50%
Adenosine
33%
Cyclooxygenase-1 (COX-1)
33%
ENT2
33%
Nucleoside Transporters
33%
Sulindac
33%
Kinetic Study
16%
Antiproliferative Activity
16%
IC50 Value
16%
Competitive Inhibitor
16%
Indomethacin
16%
Pharmacological Effects
16%
Adenosine Receptors
16%
Clinical Efficacy
16%
Pharmacological Activities
16%
Naproxen
16%
Active Metabolite
16%
Extracellular Adenosine
16%
Mefenamic Acid
16%
Aspirin
16%
Etodolac
16%
Equilibrative nucleoside Transporter
16%
Ketoprofen
16%
Piroxicam
16%
A2B Adenosine Receptor
16%
Ribonucleosides
16%
A2B Receptor Antagonists
16%
Pharmacology, Toxicology and Pharmaceutical Science
Non-Steroidal Anti-Inflammatory Drug
100%
Adenosine
100%
Sulindac Sulfide
45%
Equilibrative Nucleoside Transporter 2
18%
Prostaglandin Synthase
18%
Sulindac
18%
Competitive Inhibitor
9%
Piroxicam
9%
Indometacin
9%
Ibuprofen
9%
Naproxen
9%
Active Metabolite
9%
Acetylsalicylic Acid
9%
Etodolac
9%
Nucleoside Transporter
9%
Ketoprofen
9%
Drug Action
9%
IC50
9%
Receptor Antagonist
9%
Adenosine Receptor
9%
Nucleoside
9%
Mefenamic Acid
9%
Equilibrative Nucleoside Transporter 1
9%
Ribonucleoside
9%